StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)

Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –

Innoviva pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Innoviva's pe ratio was 4.6× on Nov 11, 2026, against 29.2× a year earlier. Over the last 5 years it ranged from 3.5× to 29.2×, with a median of 6.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.6×−24.1
2025Jan 31, 202528.7×+2.0
2024Dec 31, 202426.7×+4.1
2023Dec 29, 202322.6×+18.4
2022Dec 30, 20224.2×−1.4
2021Dec 31, 20215.5×−0.8
2020Dec 31, 20206.3×+2.1
2019Dec 31, 20194.2×−6.1
2018Dec 31, 201810.3×−5.8
2017Dec 29, 201716.1×−15.3
2016Dec 30, 201631.5×–

More Innoviva figures

See a number that looks wrong?